ADIM
LH icon

Alpha DNA Investment Management’s Labcorp LH Stock Holding History

Alpha DNA Investment Management’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-27
Closed -$5K – 392
2021
Q1 		$5K Buy
+27
New +$5.42K 0.01% 366

Other funds holding LH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MCM
Melvin Capital Management New York $9.86B AUM 16.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Alpha DNA Investment Management's LH Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of Labcorp (LH) in Q2 2021, closing a stake of 27 shares — an estimated $5K sold.

Alpha DNA Investment Management first reported a position in LH in Q1 2021 and held it in 1 quarter. The position peaked at $5K in Q1 2021. 948 funds tracked by Wall St. Rank hold LH as of Q2 2021.

  • Alpha DNA Investment Management reported no remaining Labcorp position as of Q2 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 27 Labcorp shares in Q2 2021, an estimated $5K.
  • Alpha DNA Investment Management first reported a position in Labcorp in Q1 2021 and held it in 1 quarter.
  • Alpha DNA Investment Management's Labcorp position peaked at $5K in Q1 2021.
  • 948 funds tracked by Wall St. Rank held Labcorp as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.